Cargando…
Consensus Paper—ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia
The rarity of severe complications of this disease in children makes randomized clinical trials in immune thrombocytopenia (ITP) unfeasible. Therefore, the current management recommendations for ITP are largely dependent on clinical expertise and observations. As part of its discussions during the I...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900598/ https://www.ncbi.nlm.nih.gov/pubmed/20358200 http://dx.doi.org/10.1007/s00277-010-0941-1 |